Global Female Contraception Drug Sales Market Report 2024
The global Female Contraception Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Female Contraception Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
AG-890
Amphora
BAY-1007626
Drospirenone
Others
Segment by Application
Clinic
Hospital
Homecare
The Female Contraception Drug market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Female Contraception Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
Table of Content
1 Female Contraception Drug Market Overview
1.1 Female Contraception Drug Product Scope
1.2 Female Contraception Drug Segment by Type
1.2.1 Global Female Contraception Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 AG-890
1.2.3 Amphora
1.2.4 BAY-1007626
1.2.5 Drospirenone
1.2.6 Others
1.3 Female Contraception Drug Segment by Application
1.3.1 Global Female Contraception Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Female Contraception Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Female Contraception Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Female Contraception Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Female Contraception Drug Price Trends (2016-2027)
2 Female Contraception Drug Estimates and Forecasts by Region
2.1 Global Female Contraception Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Female Contraception Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Female Contraception Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Female Contraception Drug Revenue Market Share by Region (2016-2021)
2.3 Global Female Contraception Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Female Contraception Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Female Contraception Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Female Contraception Drug Estimates and Projections (2016-2027)
2.4.2 Europe Female Contraception Drug Estimates and Projections (2016-2027)
2.4.3 China Female Contraception Drug Estimates and Projections (2016-2027)
2.4.4 Japan Female Contraception Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Female Contraception Drug Estimates and Projections (2016-2027)
2.4.6 India Female Contraception Drug Estimates and Projections (2016-2027)
3 Global Female Contraception Drug Competition Landscape by Players
3.1 Global Top Female Contraception Drug Players by Sales (2016-2021)
3.2 Global Top Female Contraception Drug Players by Revenue (2016-2021)
3.3 Global Female Contraception Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Contraception Drug as of 2020)
3.4 Global Female Contraception Drug Average Price by Company (2016-2021)
3.5 Manufacturers Female Contraception Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Female Contraception Drug Market Size by Type
4.1 Global Female Contraception Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Female Contraception Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Female Contraception Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Female Contraception Drug Price by Type (2016-2021)
4.2 Global Female Contraception Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Female Contraception Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Female Contraception Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Female Contraception Drug Price Forecast by Type (2022-2027)
5 Global Female Contraception Drug Market Size by Application
5.1 Global Female Contraception Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Female Contraception Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Female Contraception Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Female Contraception Drug Price by Application (2016-2021)
5.2 Global Female Contraception Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Female Contraception Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Female Contraception Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Female Contraception Drug Price Forecast by Application (2022-2027)
6 North America Female Contraception Drug Market Facts & Figures
6.1 North America Female Contraception Drug Sales by Company
6.1.1 North America Female Contraception Drug Sales by Company (2016-2021)
6.1.2 North America Female Contraception Drug Revenue by Company (2016-2021)
6.2 North America Female Contraception Drug Sales Breakdown by Type
6.2.1 North America Female Contraception Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Female Contraception Drug Sales Breakdown by Type (2022-2027)
6.3 North America Female Contraception Drug Sales Breakdown by Application
6.3.1 North America Female Contraception Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Female Contraception Drug Sales Breakdown by Application (2022-2027)
7 Europe Female Contraception Drug Market Facts & Figures
7.1 Europe Female Contraception Drug Sales by Company
7.1.1 Europe Female Contraception Drug Sales by Company (2016-2021)
7.1.2 Europe Female Contraception Drug Revenue by Company (2016-2021)
7.2 Europe Female Contraception Drug Sales Breakdown by Type
7.2.1 Europe Female Contraception Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Female Contraception Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Female Contraception Drug Sales Breakdown by Application
7.3.1 Europe 122 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 122 Sales Breakdown by Application (2022-2027)
8 China Female Contraception Drug Market Facts & Figures
8.1 China Female Contraception Drug Sales by Company
8.1.1 China Female Contraception Drug Sales by Company (2016-2021)
8.1.2 China Female Contraception Drug Revenue by Company (2016-2021)
8.2 China Female Contraception Drug Sales Breakdown by Type
8.2.1 China Female Contraception Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Female Contraception Drug Sales Breakdown by Type (2022-2027)
8.3 China Female Contraception Drug Sales Breakdown by Application
8.3.1 China 143 Sales Breakdown by Application (2016-2021)
8.3.2 China 143 Sales Breakdown by Application (2022-2027)
9 Japan Female Contraception Drug Market Facts & Figures
9.1 Japan Female Contraception Drug Sales by Company
9.1.1 Japan Female Contraception Drug Sales by Company (2016-2021)
9.1.2 Japan Female Contraception Drug Revenue by Company (2016-2021)
9.2 Japan Female Contraception Drug Sales Breakdown by Type
9.2.1 Japan Female Contraception Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Female Contraception Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Female Contraception Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Female Contraception Drug Market Facts & Figures
10.1 Southeast Asia Female Contraception Drug Sales by Company
10.1.1 Southeast Asia Female Contraception Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Female Contraception Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Female Contraception Drug Sales Breakdown by Type
10.2.1 Southeast Asia Female Contraception Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Female Contraception Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Female Contraception Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Female Contraception Drug Market Facts & Figures
11.1 India Female Contraception Drug Sales by Company
11.1.1 India Female Contraception Drug Sales by Company (2016-2021)
11.1.2 India Female Contraception Drug Revenue by Company (2016-2021)
11.2 India Female Contraception Drug Sales Breakdown by Type
11.2.1 India Female Contraception Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Female Contraception Drug Sales Breakdown by Type (2022-2027)
11.3 India Female Contraception Drug Sales Breakdown by Application
11.3.1 India Female Contraception Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Female Contraception Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Female Contraception Drug Business
12.1 Addex Therapeutics Ltd
12.1.1 Addex Therapeutics Ltd Corporation Information
12.1.2 Addex Therapeutics Ltd Business Overview
12.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Addex Therapeutics Ltd Female Contraception Drug Products Offered
12.1.5 Addex Therapeutics Ltd Recent Development
12.2 Agile Therapeutics Inc
12.2.1 Agile Therapeutics Inc Corporation Information
12.2.2 Agile Therapeutics Inc Business Overview
12.2.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Agile Therapeutics Inc Female Contraception Drug Products Offered
12.2.5 Agile Therapeutics Inc Recent Development
12.3 Bayer AG
12.3.1 Bayer AG Corporation Information
12.3.2 Bayer AG Business Overview
12.3.3 Bayer AG Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer AG Female Contraception Drug Products Offered
12.3.5 Bayer AG Recent Development
12.4 Evofem Inc
12.4.1 Evofem Inc Corporation Information
12.4.2 Evofem Inc Business Overview
12.4.3 Evofem Inc Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Evofem Inc Female Contraception Drug Products Offered
12.4.5 Evofem Inc Recent Development
12.5 Hervana Ltd
12.5.1 Hervana Ltd Corporation Information
12.5.2 Hervana Ltd Business Overview
12.5.3 Hervana Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hervana Ltd Female Contraception Drug Products Offered
12.5.5 Hervana Ltd Recent Development
12.6 Mithra Pharmaceuticals SA
12.6.1 Mithra Pharmaceuticals SA Corporation Information
12.6.2 Mithra Pharmaceuticals SA Business Overview
12.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Mithra Pharmaceuticals SA Female Contraception Drug Products Offered
12.6.5 Mithra Pharmaceuticals SA Recent Development
12.7 Orbis Biosciences Inc
12.7.1 Orbis Biosciences Inc Corporation Information
12.7.2 Orbis Biosciences Inc Business Overview
12.7.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Orbis Biosciences Inc Female Contraception Drug Products Offered
12.7.5 Orbis Biosciences Inc Recent Development
12.8 Teva Pharmaceutical Industries Ltd
12.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.8.2 Teva Pharmaceutical Industries Ltd Business Overview
12.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Teva Pharmaceutical Industries Ltd Female Contraception Drug Products Offered
12.8.5 Teva Pharmaceutical Industries Ltd Recent Development
12.9 Viramal Ltd
12.9.1 Viramal Ltd Corporation Information
12.9.2 Viramal Ltd Business Overview
12.9.3 Viramal Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Viramal Ltd Female Contraception Drug Products Offered
12.9.5 Viramal Ltd Recent Development
13 Female Contraception Drug Manufacturing Cost Analysis
13.1 Female Contraception Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Female Contraception Drug
13.4 Female Contraception Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Female Contraception Drug Distributors List
14.3 Female Contraception Drug Customers
15 Market Dynamics
15.1 Female Contraception Drug Market Trends
15.2 Female Contraception Drug Drivers
15.3 Female Contraception Drug Market Challenges
15.4 Female Contraception Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer